Assessing the Effect of the 'Wavy' Application, on Stress and Burden of Disease in Women With INOCA
NCT06171893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117
Last updated 2024-01-19
Summary
For women that experience angina symptoms with underlying vascular spasm as the cause, stress has an aggravating role. Coping with stress is therefore included as an important pillar in dealing with this chronic disease, see the European Association of Percutaneous Cardiovascular Interventions (EACPI) consensus document on INOCA. In practice, stress management focuses on informing and identifying the role stress plays in their lives. A potential stress management tool: "Wavy" aims to help users manage stress more consciously through biofeedback. This research focuses on the effectiveness of stress management applications. The hypothesis is that the app will help to avoid the trigger stress as much as possible and thus reduce the burden of disease.
Conditions
- Stress
- Ischemia
- Vasospasm, Coronary
- Vasomotor; Spasm
- Angina, Stable
- Prinzmetal Angina
Interventions
- BEHAVIORAL
-
Wavy stress application
The intervention consists of the application named Wavy. Wavy uses artificial intelligence and the user's feedback to detect stress increasingly more efficient over time. This provides not only real-time feedback on an individual's stress level but also helps the patient to calm down using music guided relaxation. It does so with a music filter, allowing the participant to listen to music where the stress level determines the quality of the music. Thus, relaxing is rewarded by improving the experience. In this process, implicit learning is used to establish a habit of getting better at recognising increased stress levels and getting familiar with reducing stress levels more and more effectively.
Sponsors & Collaborators
-
VieCuri Medical Centre
collaborator OTHER -
The Elisabeth-TweeSteden Hospital
collaborator OTHER -
Maastricht University Medical Center
collaborator OTHER -
Maasstad Hospital
collaborator OTHER -
Catharina Ziekenhuis Eindhoven
collaborator OTHER -
ZonMw: The Netherlands Organisation for Health Research and Development
collaborator OTHER -
Health Holland
collaborator OTHER -
Netherlands Organisation for Scientific Research
collaborator OTHER_GOV -
Radboud University Medical Center
lead OTHER
Principal Investigators
-
Suzette Elias-Smale, dr. · Radboud University Medical Center
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-01
- Primary Completion
- 2022-12-23
- Completion
- 2022-12-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Investigating the Effects of Dietary Nitrate on Vascular Function, Platelet Reactivity and Restenosis in Stable Angina
NCT02529189 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Refractory Angina Pectoris by Shock Wave Therapy
NCT00776568 ·Status: UNKNOWN ·Phase: PHASE3
-
Physiologic Effect of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock.
NCT05102734 ·Status: COMPLETED
-
Physiological Assessment of the Endothelium - Circadian Rhythm and Role of the Sympathetic Nervous System
NCT01713374 ·Status: COMPLETED ·Phase: NA
-
Mental Stress, Autonomic Function, and Heart Disease
NCT00005524 ·Status: COMPLETED
-
Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy Subjects
NCT00001963 ·Status: COMPLETED ·Phase: PHASE1
-
Inorganic Nitrate as a Treatment for ANOCA: NO-ANOCA
NCT06948201 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences
NCT05997732 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation
NCT00348101 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction
NCT05168462 ·Status: RECRUITING ·Phase: PHASE4
-
The Nitrite and Coronary Flow Study
NCT04354051 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Empiric Quinidine for Asymptomatic Brugada Syndrome
NCT00789165 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol
NCT01404767 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart
NCT01798992 ·Status: COMPLETED ·Phase: PHASE4
-
Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction
NCT00573144 ·Status: COMPLETED ·Phase: PHASE2
-
Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
NCT06263452 ·Status: RECRUITING ·Phase: PHASE4
-
Anxiety and Vagal Control of the Heart in Coronary Disease
NCT00006311 ·Status: COMPLETED
-
Effect of Topically-applied Milrinone or Nitroglycerin on Internal Mammary Artery Free Flow
NCT06301880 ·Status: COMPLETED ·Phase: PHASE3
-
Early Neurovascular Adaptations in Aging Women
NCT06520982 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Metoprolol and Trimetazidine for Coronary Heart Disease With Angina
NCT07074834 ·Status: COMPLETED ·Phase: NA
-
Endothelin Receptor Function and Acute Stress
NCT02116335 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease
NCT00069654 ·Status: COMPLETED ·Phase: PHASE2
-
Extracorporeal Shockwave Therapy for the Treatment of Refractory Chronic Angina Pectoris
NCT01567644 ·Status: UNKNOWN ·Phase: PHASE1
-
Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy
NCT01631409 ·Status: WITHDRAWN
-
Effect of NT-proBNP Guided Treatment of Chronic Heart Failure
NCT00149422 ·Status: COMPLETED ·Phase: NA